ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,058Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1269

$1.03M Total Retail Price of All Prescriptions

Rank: 22 out of 1269

735 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 735 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 735 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,135 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 558 417 1 3
BYSTOLIC 545 329 2 126
FUROSEMIDE 461 269 3 5
METFORMIN HCL 433 267 4 9
AMLODIPINE BESYLATE 374 290 5 2
LISINOPRIL 352 225 6 1
LOSARTAN-HYDROCHLOROTHIAZIDE 340 255 7 59
ATORVASTATIN CALCIUM 332 222 8 7
ZOLPIDEM TARTRATE 299 152 9 19
CRESTOR 280 160 10 25
LOVAZA 276 208 11 199
OXYCODONE HCL 272 53 S2 12 34
HYDROCHLOROTHIAZIDE 246 156 13 10
METOPROLOL TARTRATE 242 205 14 6
OMEPRAZOLE 241 134 15 8
LOSARTAN POTASSIUM 225 138 16 15
TRAMADOL HCL 224 121 17 16
OXYCODONE-ACETAMINOPHEN 209 90 S2 18 44
CARVEDILOL 205 121 19 29
PANTOPRAZOLE SODIUM 203 129 20 18
PRAVASTATIN SODIUM 199 136 21 11
NEXIUM 187 110 22 41
DIOVAN 181 152 23 35
ATENOLOL 181 135 23 14
DIOVAN HCT 176 121 25 76
NIFEDIPINE ER 171 107 26 65
HYDRALAZINE HCL 156 117 27 48
CLONIDINE HCL 156 78 27 51
LEVOTHYROXINE SODIUM 146 106 29 4
SINGULAIR 136 75 30 123
NAMENDA 132 131 31 38
GABAPENTIN 122 51 32 17
ALLOPURINOL 122 81 32 49
LYRICA 121 53 34 92
ALENDRONATE SODIUM 117 91 35 28
IBUPROFEN 111 58 36 73
ADVAIR DISKUS 111 72 36 46
AMLODIPINE BESYLATE-BENAZEPRIL 103 71 38 81
GLIPIZIDE 101 73 39 37
ENDOCET 99 30 S2 40 106
RANITIDINE HCL 97 43 41 27
CLOPIDOGREL 90 76 42 32
COLCRYS 88 60 43 150
LANTUS 88 37 43 39
PLAVIX 87 66 45 47
METOPROLOL SUCCINATE 87 45 45 13
PROMETHAZINE HCL 87 0 R 45 149
VENTOLIN HFA 87 57 45 100
AZITHROMYCIN 86 49 49 42
MONTELUKAST SODIUM 85 48 50 218
EXFORGE 83 71 51 181
GLYBURIDE 79 36 R 52 94
OXYCODONE HCL-ACETAMINOPHEN 77 25 S2 53 121
CELEBREX 75 56 54 95
HYDROCODONE-ACETAMINOPHEN 70 37 S3 55 20
BENICAR HCT 69 43 56 170
INSULIN SYRINGE 68 41 57 87
LANTUS SOLOSTAR 68 52 57 144
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 39 59 33
AZOR 65 41 60 345
POTASSIUM CHLORIDE 65 26 60 26
BENICAR 64 29 62 153
EXFORGE HCT 63 33 63 309
WARFARIN SODIUM 61 46 64 12
SYMBICORT 61 46 64 173
ZETIA 61 42 64 99
ENABLEX 60 44 67 257
CYCLOBENZAPRINE HCL 60 25 R 67 93
KLOR-CON M20 58 53 69 60
SPIRIVA 57 48 70 64
MIRTAZAPINE 57 41 70 24
JANUVIA 57 44 70 74
LIVALO 57 28 70 367
PROAIR HFA 57 32 70 61
WELCHOL 56 40 75 255
SERTRALINE HCL 54 23 76 23
LEVETIRACETAM 54 35 76 55
TRAMADOL HCL-ACETAMINOPHEN 53 17 78 164
ATELVIA 53 53 78 247
VESICARE 52 28 80 241
TAMSULOSIN HCL 52 46 80 31
HUMALOG 50 0 82 109
VERAPAMIL ER 50 30 82 134
CYMBALTA 50 26 82 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.